Potential predictive biomarker of response to VEGF treatment in metastatic kidney cancer
A recent study published on PLOS/ONE has identified three genetic mutations/alterations [...]
ESOU 2019: First-line treatment for metastatic renal cell carcinoma – where do we stand?
The following review of the literature for first-line treatment of [...]
Potential biomarkers may predict response to TKIs in metastatic kidney cancer
A recent study published in Clinical Cancer Research and conducted in [...]
Management of bone metastases in renal cell carcinoma
The following video from Practise Update is an interview with [...]
Nivolumab and cabozantinib accepted for use within NHS Scotland for advanced kidney cancer
The Scottish Medicines Consortium (SMC), which reviews newly licensed medicines, [...]
Aflibercept shows promise in second-line treatment of advanced kidney cancer
A study reported in the online PracticeUpdate journal Renal Cell [...]
Immunotherapy combined with VEGF inhibitors for kidney cancer
In this video interview, Dr Shilpa Gupta, assistant professor, Haematology, [...]
Management of renal medullary carcinoma
Renal medullary carcinoma is a very rare subtype of renal [...]
